Model 1 Quality system (overall) | 1: Policy and strategy | 2: Human resource management | 3: Patient involvement | 4: Practice guidelines | 5: Systematic quality improvement | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Outcome | Estimate (SE) | R2 | Estimate (SE) | R2 | Estimate (SE) | R2 | Estimate (SE) | R2 | Estimate (SE) | R2 | Estimate (SE) | R2 |
Time-out procedure | −1.89 (0.82) | 32.3 | − 1.33 (0.66) | 25.4 | − 1.25 (0.89) | 11.4 | −0.16 (0.38) | 0.9 | −1.08 (0.74) | 13.7 | −0.57 (0.37) | 14.7 |
- Check patient | −2.49 (1.13) | 43.5 | −1.65 (0.88) | 36.2 | – | – | −0.73 (0.40) | 36.0 | – | – | 0.19 (0.51) | 6.1 |
- Check procedure | −2.61 (1.37) | 18.3 | −1.46 (1.06) | 9.6 | −1.78 (1.48) | 5.2 | −0.18 (0.58) | −1.2 | −1.02 (1.13) | 3.3 | −1.02 (0.55) | 16.8 |
- Check side/site | −0.96 (0.49) | 40.8 | −0.32 (0.44) | 8.8 | −0.40 (0.54) | 8.8 | −0.59 (0.14) | 8.5 | 0.09 (0.46) | −0.5 | −0.02 (0.23) | 1.0 |
- Focus during TOP | −0.75 (0.62) | 8.8 | −0.45 (0.50) | 4.8 | −0.28 (0.61) | −0.1 | − 0.39 (0.24) | 15.8 | − 0.08 (0.53) | −1.9 | −0.02 (0.27) | −1.7 |
Contrast- induced nephropathy | 0.86 (0.68) | 0.11 | 0.29 (0.44)** | 14.0 | −0.08 (0.63) | −0.9 | 0.55 (0.25)* | 30.8 | −0.11 (0.45) | −1.7 | −0.17 (0.29) | 2.2 |
Pain process indicator 100% | 0.09 (0.98) | −0.5 | −0.55 (0.75) | 2.3 | 0.41 (0.89) | 0.1 | 0.28 (0.37) | 7.3 | −0.66 (0.62) | 5.8 | 0.12 (0.40) | −0.2 |
Medication reconciliation on admission | 0.64 (1.40) | −1.3 | 0.53 (0.99) | −0.9 | 0.42 (1.06) | −5.5 | 0.97 (0.76) | 8.4 | −0.41 (1.00) | −3.8 | −0.13 (0.67) | −7.5 |
Medication reconciliation at discharge | 1.01 (1.30) | 6.3 | 1.73 (0.87)* | 26.0 | −0.64 (0.87) | 5.0 | −0.002 (0.74) | −0.8 | 1.33 (0.92) | 16.6 | 0.21 (0.59) | 3.1 |
High-Risk Medication | 0.51 (0.91) | 2.4 | −0.04 (0.68) | −1.2 | −0.81 (0.61) | 12.0 | 0.89 (0.42)* | 28.4 | 0.20 (0.66) | 0.1 | 0.20 (0.45) | −0.1 |